What in the world? Who could’ve known?
It’s too bad that 99% of journalists have been working steadfastly for the FDA, CDC and NIH.
If they were complicit, they might ask a hard question and also why the FDA just approved for infants.
The excess risk of serious adverse events of special interest surpassed the risk reduction for COVID-19 hospitalization relative to the placebo group in both Pfizer and Moderna trials (2.3 and 6.4 per 10,000 participants, respectively).
Discussion: The excess risk of serious adverse events found in our study points to the need for formal harm-benefit analyses, particularly those that are stratified according to risk of serious COVID-19 outcomes such as hospitalization or death.